Home > Financial Ratios > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
EV/Core EBITDA

    Back to All Ratios
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 23.6126.5119.2419.0315.10

What is the latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES ?

The latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES is 23.61 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202523.61
Mar202426.51
Mar202319.24
Mar202219.03
Mar202115.10

How is EV/Core EBITDA of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years EV/Core EBITDA % Change
Mar2025 23.61
-10.94
Mar2024 26.51
37.79
Mar2023 19.24
1.10
Mar2022 19.03
26.03
Mar2021 15.1 -

Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES


Compare EV/Core EBITDA ratio of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹391,601.7 Cr -5.9% -2.8% -5.3% Stock Analytics
DIVIS LABORATORIES ₹170,148.0 Cr -3.7% -6.9% 30.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,471.0 Cr -3.8% 7.1% 12% Stock Analytics
CIPLA ₹121,103.0 Cr -3.9% -0.8% -0.9% Stock Analytics
MANKIND PHARMA ₹108,009.0 Cr 1.6% 8.4% 31.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,306.0 Cr -6% -7.3% -12% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

-5.9%

-2.8%

-5.3%

SENSEX

-0.8%

-3.3%

-1.4%


You may also like the below Video Courses